Rani Therapeutics Holdings Balance Sheet Health
Financial Health criteria checks 3/6
Rani Therapeutics Holdings has a total shareholder equity of $25.4M and total debt of $29.4M, which brings its debt-to-equity ratio to 115.5%. Its total assets and total liabilities are $57.9M and $32.5M respectively.
Key information
115.5%
Debt to equity ratio
US$29.38m
Debt
| Interest coverage ratio | n/a |
| Cash | US$48.54m |
| Equity | US$25.44m |
| Total liabilities | US$32.47m |
| Total assets | US$57.92m |
Financial Position Analysis
Short Term Liabilities: RANI's short term assets ($50.8M) exceed its short term liabilities ($8.0M).
Long Term Liabilities: RANI's short term assets ($50.8M) exceed its long term liabilities ($24.5M).
Debt to Equity History and Analysis
Debt Level: RANI has more cash than its total debt.
Reducing Debt: Insufficient data to determine if RANI's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RANI has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: RANI has less than a year of cash runway if free cash flow continues to reduce at historical rates of 30.3% each year